Searched for
VIYASH SCIENTIFIC
Quant Small Cap Fund exits SBI Funds Management, Jubilant FoodWorks and 4 other stocks in AugustQuant Small Cap Fund, managed by Quant Mutual Fund, exited six stocks and added four new names in August 2026. The fund increased exposure ...- Block, bulk deals hit 14-month high in August at Rs 80,000 croreBlock and bulk trades worth at least ₹80,000 crore were executed during the month - the highest since June 2025. Domestic mutual funds, ins...
- Reliance Industries, Groww and MTAR Technologies among stocks bought and sold by mutual funds in JuneMutual funds invested Rs 50,600 crore in stocks during June. They significantly bought JSWInfra, Bajaj Finance, and HDFC Bank. Conversely, ...
- Quant Small Cap Fund exits RIL, 8 others; raises exposure to two Adani stocks. Check full listQuant Small Cap Fund made a major portfolio reshuffle in June, exiting Reliance Industries and eight other stocks while increasing exposure...
- Top picks! Redington among 5 stocks with upside potential of up to 27%. Do you own any?Monarch Networth Capital has maintained Buy ratings on Pricol, Redington, Sundram Fasteners, Travel Food Services and Viyash Scientific, ci...
- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
- Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 croreViyash Scientific, backed by Carlyle, is acquiring Italy's BioForLife for Rs. 188 crore. This move aims to build a leading global companion...
- Boehringer Ingelheim, Viyash Scientific enter pet healthcare pact in IndiaGerman biopharma giant Boehringer Ingelheim is partnering with Viyash Scientific to bring its pet healthcare products to India. This collab...
- Sequent-Viyash may soon have zero debt: Viyash founder and combined co's CEO-designate Hari Babu Bodepudi to inject ₹400 croreHari Babu Bodepudi is making a significant capital infusion into the newly merged Sequent Scientific and Viyash Life Sciences. This strateg...
- NCLT clears Sequent Scientific–Viyash Life Sciences merger worth ₹8,000 croreCarlyle's portfolio companies, Sequent Scientific and Viyash Life Sciences, have received National Company Law Tribunal approval for their ...
- Sequent and Viyash Life merger plan gets shareholder approvalThe proposed merger of Sequent Scientific and Viyash Life Sciences, backed by Carlyle, has received overwhelming shareholder support. This ...
- Carlyle portfolio firms SeQuent Scientific and Viyash Life get stock exchange nod for mergerCarlyle-backed SeQuent Scientific and Viyash Life Sciences have secured stock exchange approvals for their merger. Next, they will approach...
- CCI clears merger of nine pharma entities with Sequent ScientificThe Competition Commission of India has approved the amalgamation of nine entities into Sequent Scientific Ltd (SSL), enhancing its positio...
- Sequent to absorb Viyash, giving 56 for 100 sharesIn a stock exchange filing, Sequent Scientific said its board has approved a proposal to merge Viyash Life Sciences and its group companies...
- Sequent Scientific shares soar 18% on Rs 8,000 crore merger with Viyash Life SciencesSequent Scientific and Viyash Life Sciences have announced a merger that will result in the two companies forming a combination that will c...
- Sequent Scientific, Viyash Life Sciences announce Rs 8,000 crore mergerSequent Scientific and Viyash Life Sciences have announced a merger, creating a platform with leadership in animal pharmaceuticals and inte...
- Carlyle Group portfolio companies in advanced talks for a potential mergerSequent Scientific, which is in animal health business, posted revenue of around Rs 1,400 crore in FY24. It had earnings before interest, t...
- Sequent Scientific, Viyash Life Sciences explore merger worth Rs 7000-8000 crSequent Scientific and Viyash Life Sciences are discussing a potential merger valued at Rs. 7000-8000 crore. Both companies' boards will me...
- Carlyle, Viyash Life Sciences to launch pharma investment platformCA Hull Investments, an affiliated entity of Carlyle Asia Partners and Viyash, and the platform will primarily focus on investment in Activ...
- PE Fund Carlyle partners Viyash for generics platformCA Hull Investments, an affiliated entity of CAP V Mauritius and Carlyle, and Viyash, have set up the platform, an official statement said,...
Load More
